Nonprofit · EIN 23-7045686
INFECTIOUS DISEASES SOCIETY OF AMERICA INC
Tax-exempt · ARLINGTON, VA 22203
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $32,259,941 | $39,521,191 | -$7,261,250 | $66,284,980 | $17,232,049 | $49,052,931 |
| December 31, 2023 | 990 | $37,618,238 | $37,463,898 | $154,340 | $68,105,366 | $16,278,116 | $51,827,250 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $1,416,910
- of which government grants
- $1,131,324
- Program service revenue
- $28,617,663
- Investment income
- $1,475,671
- Royalties
- $552,121
- Other revenue
- $749,697
Expenses
- Grants and similar amounts paid
- $1,060,246
- Compensation of officers, directors and key employees
- $2,702,916
- Other salaries and wages
- $10,499,131
- Salaries, compensation and benefits (total)
- $15,558,551
- Professional fundraising fees
- $0
- Legal fees
- $213,573
- Accounting fees
- $57,023
- Occupancy
- $808,969
- Travel
- $1,526,650
- Depreciation
- $426,092
Balance sheet and other
- Total assets, start of year
- $68,105,366
- Total assets, end of year
- $66,284,980
- Total liabilities, end of year
- $17,232,049
- Net assets, end of year
- $49,052,931
- Land, buildings and equipment
- $1,512,600
- Publicly traded securities
- $44,930,525
- Net assets without donor restrictions
- $49,052,931
- Gross unrelated business income
- $69,463
- Gross receipts
- $32,259,941
- Employees
- 120
- Volunteers
- 700
- Year formed
- 1970
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CHRISTOPHER BUSKY CAE | CHIEF EXECUTIVE OFFICER Officer | 32.5 | $711,141 | $15,664 | $86,330 |
| TY JOHNSON | CHIEF OPERATING OFFICER Officer | 22.5 | $326,268 | $104,406 | $39,915 |
| DANA WOLLINS | SVP, STRATEGY Key employee | 37.5 | $284,741 | $0 | $59,916 |
| AMANDA JEZEK | SVP, POLICY & GOVERNMENT RELATIONS Key employee | 37.5 | $273,303 | $0 | $56,806 |
| SANDRA VURA HARWOOD | VP, MEETINGS & EDUCATION Key employee | 37.5 | $262,084 | $0 | $44,668 |
| FELICITY CLANCY | VP, MARKETING & MEMBERSHIP Highest-paid employee | 37.5 | $242,469 | $0 | $55,197 |
| BARTON GROH | VP, FINANCE & ADMINISTRATION Officer | 30.5 | $223,970 | $11,945 | $47,706 |
| SALANDRA THOMAS | VP, TALENT & ORG. DEVELOPMENT Highest-paid employee | 34.5 | $228,380 | $6,090 | $46,179 |
| ANDREA WEDDLE | ED, HIVMA Key employee | 36.5 | $239,037 | $6,374 | $33,546 |
| GAYLE LEVY HARTMAN | SENIOR DIRECTOR, DIGITAL & CONTENT STRATEGY Highest-paid employee | 37.5 | $169,138 | $0 | $53,519 |
| JENNIFER MORALES | SENIOR DIRECTOR, PR & MARKETING Highest-paid employee | 37.5 | $177,935 | $0 | $29,493 |
| RACHEL SHNEKENDORF | SENIOR DIRECTOR, EDUCATION Highest-paid employee | 37.5 | $179,665 | $0 | $26,955 |
| STEVEN K SCHMITT MD | IMMED. PAST PRESIDENT AS OF 10/2024 Trustee or director, Officer | 2 | $25,000 | $0 | $0 |
| TINA Q TAN MD | PRESIDENT AS OF 10/2024 Trustee or director, Officer | 2 | $7,500 | $0 | $0 |
| CARLOS DEL RIO MD | IMMED. PAST PRESIDENT UNTIL 10/2024 Trustee or director, Officer | 2 | $0 | $0 | $0 |
13 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| RONALD NAHASS MD | PRESIDENT ELECT AS OF 10/2024 Trustee or director, Officer | 2 | $0 |
| WENDY S ARMSTRONG MD | VICE PRESIDENT AS OF 10/2024 Trustee or director, Officer | 2 | $0 |
| MAXIMO BRITO MD | TREASURER Trustee or director, Officer | 2 | $0 |
| ROBIN TROTMAN MD | SECRETARY Trustee or director, Officer | 2 | $0 |
| ERIN BONURA MD | DIRECTOR Trustee or director | 1 | $0 |
| ROBIN HENRY DRETLER MD | DIRECTOR Trustee or director | 1 | $0 |
| MATIFADZA HLATSHWAYO DAVIS MD MPH | DIRECTOR Trustee or director | 1 | $0 |
| HEATHER C YUN MD | DIRECTOR Trustee or director | 1 | $0 |
| BONNIE M WORD MD | DIRECTOR Trustee or director | 1 | $0 |
| DAVID ARONOFF MD | DIRECTOR AS OF 10/2024 Trustee or director | 1 | $0 |
| UPINDER SINGH MD | DIRECTOR AS OF 10/2024 Trustee or director | 1 | $0 |
| RAJESH T GHANDI MD | DIRECTOR Trustee or director | 1 | $0 |
| KAMI KIM MD | DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 33 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CHRISTOPHER BUSKY CAE | CHIEF EXECUTIVE OFFICER Officer | 36.5 | $571,440 | $13,048 | $56,143 |
| TY JOHNSON | CHIEF OPERATING OFFICER Officer | 25 | $291,719 | $121,909 | $20,646 |
| DANA WOLLINS | SVP, STRATEGY Key employee | 37.5 | $289,970 | $0 | $26,441 |
| AMANDA JEZEK | SVP, POLICY & GOV. RELATIONS Key employee | 37.5 | $286,139 | $0 | $21,485 |
| SANDRA VURA HARDWOOD | VP, MEETINGS AND EDUCATION Key employee | 37.5 | $281,761 | $0 | $21,936 |
| FELICITY CLANCY | VP, MARKETING AND MEMBERSHIP Highest-paid employee | 37.5 | $258,862 | $0 | $22,375 |
| SALANDRA THOMAS | VP, TALENT AND ORGANIZATIONAL DEVELOPMENT Highest-paid employee | 36.5 | $241,118 | $5,921 | $19,578 |
| ANDREA WEDDLE | ED, HIVMA Key employee | 36.5 | $243,666 | $5,991 | $14,935 |
| BARTON GROH | VP, FINANCE AND ADMINISTRATION Officer | 32.5 | $236,612 | $5,797 | $19,234 |
| GAYLE LEVY HARTMAN | SR. DIR., DIGITAL AND CONTENT STRATEGY Highest-paid employee | 37.5 | $172,458 | $0 | $20,803 |
| JENNIFER MORALES | SR. DIR., PR & MARKETING Highest-paid employee | 37.5 | $173,291 | $0 | $11,055 |
| RACHEL SHNEKENDORF | SR. DIR., EDUCATION Highest-paid employee | 37.5 | $172,302 | $0 | $10,926 |
| CARLOS DEL RIO MD | IMMEDIATE PAST PRESIDENT Trustee or director, Officer | 2 | $45,000 | $0 | $0 |
| STEVEN K SCHMITT MD | PRESIDENT Trustee or director, Officer | 2 | $25,000 | $0 | $0 |
| TINA Q TAN MD FIDSA | PRESIDENT-ELECT Trustee or director, Officer | 2 | $0 | $0 | $0 |
| JEFFREY S DUCHIN MD FIDSA | SECRETARY THRU 05/2023 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| JEANNE MARRAZZO MD FIDSA | TREASURER THRU 10/2023 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| DAN P MCQUILLEN MD FIDSA | IMMEDIATE PAST PRESIDENT THRU 10/23 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| MAXIMO O BRITO MD FIDSA | TREASURER A/O 10/2023 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| ROBIN TROTMAN MD FIDSA | SECRETARY A/O 05/2023 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| RONALD NAHASS MD | VICE PRESIDENT A/O 10/2023 Trustee or director, Officer | 2 | $0 | $0 | $0 |
| LILIAN M ABBO MD FIDSA | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ERIN BONURA MD | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| CESAR A ARIAS MD FIDSA | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ROBIN HENRY DRETLER MD | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| RANA CHAKRABORTY MD MSC DPHIL FID | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| RAJESH T GHANDI MD FIDSA | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JASMINE MARCELIN MD FIDSA | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| BONNIE M WORD MD FIDSA | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| MATIFADZA HLATSHWAYO DAVIS MD MPH | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KAMI KIM MD | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ADA ADIMORA MD | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| HEATHER C YUN MD | MEMBER Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 4040 WILSON BLVD STE 300, ARLINGTON, VA 22203-4439
- Principal officer (990 for 2024)
- CHRISTOPHER BUSKY, 4040 WILSON BOULEVARD 300, ARLINGTON, VA 22203
- Signed the 990
- BARTON GROH, VP, FINANCE & ADMINISTRATION
- Phone
- (703) 299-0200
- Website
- WWW.IDSOCIETY.ORG
- Return prepared by
- CLIFTONLARSONALLEN LLP
Mission
THE MISSION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA) IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND PREVENTION OF INFECTIOUS DISEASES. IDSA'S WORK IS GUIDED BY A COMMITMENT TO SCIENCE, HEALTH EQUITY, AND TACKLING THE CHALLENGES OF INFECTIOUS DISEASES THROUGH ITS GLOBAL COMMUNITY OF EXPERTS.
Program accomplishments
- IDWEEK ANNUAL CONFERENCE - IDWEEK 2024 IN LOS ANGELES, CA, ATTRACTED MORE THAN 10,000 ATTENDEES. THE MEETING IS THE WORLD'S PREMIER INFECTIOUS DISEASES EVENT. IDWEEK PROVIDES AN OPPORTUNITY FOR HEALTH PROFESSIONALS OF VARIED BACKGROUNDS TO LEARN FROM EACH OTHER'S KNOWLEDGE, EXPERIENCE AND EXPERTISE, FOR THE IMPROVEMENT OF PATIENT CARE AND PUBLIC HEALTH. THIS IS AN INCLUSIVE MEETING THAT OFFERS ACCESS TO INTERNATIONALLY RECOGNIZED LEADERS IN THE FIELD AND THE OPPORTUNITY TO NETWORK WITH THE MOST HIGHLY RESPECTED HEALTH PROFESSIONALS IN INFECTIOUS DISEASES, INCLUDING HIV.
- CLINICAL INFECTIOUS DISEASES (CID), THE JOURNAL OF INFECTIOUS DISEASES (JID) AND OPEN FORUM INFECTIOUS DISEASES (OFID) ARE SCHOLARLY JOURNALS PUBLISHED BY IDSA IN PARTNERSHIP WITH AN OUTSIDE PUBLISHER TO DISSEMINATE THE LATEST RESEARCH ON A VARIETY OF TOPICS IN THE FIELD TO MEMBERS AND SUBSCRIBERS. CID PUBLISHES ORIGINAL RESEARCH, REVIEWS AND PERSPECTIVES THAT ALL CLINICIANS CAN USE WHEN CARING FOR PATIENTS. CID COVERS THE CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND PREVENTION OF THE FULL RANGE OF INFECTIOUS DISEASES. THE EVALUATION OF CURRENT AND NOVEL TREATMENTS, MICROBIOLOGY, IMMUNOLOGY AND POLICIES AS THEY RELATE TO PATIENT CARE ARE HIGHLY PRIORITIZED. PUBLISHED CONTINUOUSLY SINCE 1904, JID IS THE PREMIER GLOBAL JOURNAL FOR TRANSLATIONAL INFECTIOUS DISEASES SCIENCE. THE EDITORS WELCOME MAJOR ARTICLES AND BRIEF REPORTS DESCRIBING RESEARCH RESULTS ON MICROBIOLOGY, IMMUNOLOGY, EPIDEMIOLOGY, AND RELATED DISCIPLINES, ON THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF INFECTIOUS DISEASES; ON THE MICROBES THAT CAUSE THEM; AND ON DISORDERS OF HOST IMMUNE RESPONSES. OFID PUBLISHES CLINICAL, TRANSLATIONAL AND BASIC RESEARCH IN A FULLY OPEN ACCESS, ONLINE JOURNAL. IT FOCUSES ON THE INTERSECTION OF BIOMEDICAL SCIENCE AND CLINICAL PRACTICE, WITH AN EMPHASIS ON KNOWLEDGE THAT COULD IMPROVE PATIENT CARE GLOBALLY. ARTICLES ARE WRITTEN BY EXPERTS IN THE FIELD, INCLUDING MEMBERS AND NON-MEMBERS, AND REVIEWED BY A PANEL OF LEADING MEDICAL EXPERTS BEFORE THEY ARE PUBLISHED.
- MEMBER SERVICES - IDSA MEMBER SERVICES PROVIDES TIMELY SCIENTIFIC INFORMATION, RELEVANT PUBLIC POLICY AND REGULATION, AND CAREER DEVELOPMENT RESOURCES.
- IDSA WAS AWARDED A COOPERATIVE AGREEMENT TO SUPPORT THE CDC BY PROVIDING RESOURCES TO FRONTLINE HEALTH CARE PROFESSIONALS CARING FOR PATIENTS WITH COVID-19. THE PARTNERSHIP BRINGS NUMEROUS MEDICAL SPECIALTIES TOGETHER TO SHARE RESOURCES AND TO PROVIDE THE LATEST INFORMATION AND GUIDANCE ON TREATING THOSE INFECTED WITH COVID-19 AND PREVENTING ITS SPREAD. THROUGH FUNDING FROM CDC, IDSA EXPERTS SUPPORT CDC'S CLINICAL CALL LINES, PROVIDING GUIDANCE TO HEALTH CARE PROVIDERS TREATING COVID-19 PATIENTS. THE COLLABORATION HAS ALSO FUNDED THE FLOURISHING COVID-19 REAL-TIME LEARNING NETWORK, AN ONLINE CENTER FOR FRONTLINE CLINICIANS TO LEARN, COLLABORATE AND SHARE TREATMENT BEST PRACTICES. IDSA'S COVID-19 PRACTICE GUIDELINES ON DIAGNOSTICS, TREATMENT AND MANAGEMENT ALSO RECEIVE FUNDING THROUGH THE GRANT. ADDITIONALLY, UNDER THE PARTNERSHIP, TWICE-MONTHLY CLINICIAN TELECONFERENCES PROVIDE HEALTH CARE PROFESSIONALS ACCESS TO EXPERTS WITH THE LATEST INFORMATION ON THIS EVOLVING VIRUS AS WELL AS AN OPPORTUNITY TO ASK QUESTIONS. THE CALLS FREQUENTLY DRAW MORE THAN 800 ATTENDEES.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 23-7045686
- Tax-exempt status
- 501(c)(6): Business league or chamber of commerce
- Donations deductible
- No
- Exempt since
- 1970
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $66,284,980
- Income (IRS master file)
- $32,259,941
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $32,259,941 | $39,521,191 | $66,284,980 | IRS |
| 990 | December 2023 | $37,618,238 | $37,463,898 | $68,105,366 | XML |
| 990 | December 2022 | $34,301,211 | $32,853,700 | $66,632,887 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7045686).
Questions about INFECTIOUS DISEASES SOCIETY OF AMERICA INC
- What is the EIN of INFECTIOUS DISEASES SOCIETY OF AMERICA INC?
- The employer identification number (EIN) of INFECTIOUS DISEASES SOCIETY OF AMERICA INC is 23-7045686.
- Is INFECTIOUS DISEASES SOCIETY OF AMERICA INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1970.
- Are donations to INFECTIOUS DISEASES SOCIETY OF AMERICA INC tax-deductible?
- No. The IRS master file says contributions to it are not deductible.
- Which annual return does INFECTIOUS DISEASES SOCIETY OF AMERICA INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of INFECTIOUS DISEASES SOCIETY OF AMERICA INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did INFECTIOUS DISEASES SOCIETY OF AMERICA INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of INFECTIOUS DISEASES SOCIETY OF AMERICA INC?
- The 990 for the year ended December 31, 2024 names CHRISTOPHER BUSKY.
- Who are the officers and directors of INFECTIOUS DISEASES SOCIETY OF AMERICA INC?
- The 990 for the year ended December 31, 2024 lists 28 people; 14 received compensation from the organization, the highest $711,141 (CHRISTOPHER BUSKY CAE, CHIEF EXECUTIVE OFFICER).
- How much revenue does INFECTIOUS DISEASES SOCIETY OF AMERICA INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $32,259,941, expenses of $39,521,191 and total assets of $66,284,980 at year end.
Other nonprofits in ARLINGTON
- RAILROAD EMPLOYEES NATIONAL HEALTH AND WELFARE PLAN TRUST EIN 52-1118310 · last filed 990 for 2024
- NATURE CONSERVANCY EIN 53-0242652 · last filed 990 for 2025
- VIRGINIA HOSPITAL CENTER ARLINGTON HEALTH SYSTEM EIN 54-0505989 · last filed 990 for 2024
- NATIONAL RURAL ELECTRIC COOPERATIVE EIN 56-6208927 · last filed 990 for 2024
- PUBLIC BROADCASTING SERVICE EIN 52-0899215 · last filed 990 for 2025
- SMART - TD HEALTH AND WELFARE PLAN EIN 52-2174651 · last filed 990 for 2024
- PARTNERSHIP FOR SUPPLY CHAIN MANAGE MENT EIN 20-3258654 · last filed 990 for 2025
- AMERICAN INSTITUTES FOR RESEARCH IN THE BEHAVIORAL SCIENCES EIN 25-0965219 · last filed 990 for 2024